Express Scripts Drops Onglyza From Its 2016 Formulary
One of the largest pharmacies in the United States has dropped the diabetes drug Onglyza from its formulary, which is a list of drugs covered by insurance. Out of around 4,000 medications on the U.S. market, Express Scripts did not include 80 drugs on its 2016 formulary. If you’ve been harmed by this drug, you could have a potential Onglyza lawsuit.
Why was Onglyza excluded?
Express Scripts cites the potential health risks and the availability of safer drugs to treat type 2 diabetes as its reasons for not covering Onglyza.
This comes after a FDA vote in April 2015 by the Endocrinologic and Metabolic Drugs Advisory Committee. The committee voted 14-1 to recommend better warnings of the heart failure risk of Onglyza on the drug’s label. A previous study, known as the SAVOR study, found that Onglyza users have a 27% greater risk of hospitalization for heart failure than users who took a placebo.
In an email to Medical Marketing & Media, David Whitrap, Express Script’s senior director of corporate communications, stated: “Onglyza is associated with increased risk of hospitalization due to heart failure. The market leader, Januvia, showed no risk…With the availability of other DPP-4 inhibitors, the benefits of initiating therapy, particularly with Onglyza, over other agents is less compelling.”
What are the side effects of Onglyza?
Apart from the risk of heart failure and other heart-related injuries, Onglyza has a number of side effects, such as:
Nausea & vomiting
Urinary tract infection
Low blood sugar
Contact an Onglyza Attorney
Were you hospitalized for heart failure while taking Onglyza? You could be entitled to compensation. There were no adequate warnings of the heart failure risk associated with Onglyza, despite several studies showing the dangers of the drug. To learn more about how our Onglyza attorneys can help you, fill out our free case evaluation or call us at 888-595-2922. Follow us on Facebook or Twitter to keep updated on the most recent Onglyza lawsuit news.